The Lazarus drug
The impact of antiretroviral therapy on economic growth
Bibliographic Data
| ID | 11888682 |
|---|---|
| Authors | Anna Tompsett (0000-0002-5415-6583, Stockholm University, corresponding author) |
| Year | 2019 |
| Volume | 143 |
| Pages | 102409-102409 |
| Publication date | 2019-11-16 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Development Economics (JOURNAL) |
| Journal identifiers | ISSN: 0304-3878 • E-ISSN: 1872-6089 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jdeveco.2019.102409 |
| OpenAlex | W2984620778 |
| Language | EN |
| Citations received | 6 |
| References cited | 41 |
Does better population health lead to growth in per capita income? Theory is ambiguous and empirical evidence is very limited. In 2001, a steep fall in antiretroviral (ARV) drug prices triggered rapid and massive expansion of ARV therapy coverage in lower-income countries. Exploiting the sharp resultant changes in population health, I show that ARV therapy coverage expansion led to growth in GDP per capita. The positive effects on growth most likely persist for around four years. ARV therapy coverage expansion could explain around a third of the sub-Saharan African “growth miracle”
Antiretroviral therapy · Demographic economics · Development economics · Economic growth · Economics · Environmental health · Gross domestic product · Human immunodeficiency virus (HIV · Miracle · Per capita · Per capita income · Political science · Population · Population growth · Viral load · Economic Growth and Development · Medicine · Microfinance and Financial Inclusion · Poverty, Education, and Child Welfare · Virology
Health interventions do not cause Malthusian conflict dynamics
The impact of HIV/Aids on human capital investment in Sub‐Saharan Africa
Does enhanced HIV prevention, diagnosis, and linkage to care reduce hospitalisation in high HIV-burden communities in Zambia and South Africa? findings from the HPTN 071 (PopART) randomised trial
Distributionally sensitive measurement and valuation of population health
Estimating the welfare gains from anti-retroviral therapy in Sub-Saharan Africa
Medication against conflict
Health, Human Capital, and Development
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
Malthus to Solow
Modeling the effects of health on economic growth
Malaria Eradication in the Americas
Cost-effectiveness of HIV/Aids interventions in Africa
What determines Chinese outward FDI?
Disease and Development
Increases in Adult Life Expectancy in Rural South Africa
How Much Should We Trust Differences-In-Differences Estimates?
Mostly Harmless Econometrics
The first decade of antiretroviral therapy in Africa
Macroeconomics and health
The New Econometrics of Structural Change
The Effect of Health on Economic Growth
Cause of death and development in the US
Disease and Development
Disease and Development Revisited
The African Growth Miracle
Disease and Development
| Unique citing works | 6 |
|---|---|
| Citations per year | 1,2 |
| Citation span | 2021 - 2026 (6) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 5 |